Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. Panacea’s novel product is a blood test that can detect the presence of cancer in humans using a novel cancer biomarker named Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH), an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology.
- BC Detect® BC Detect® is a novel blood test for breast cancer diagnostics. More about BC Detect® ›
- CC Detect® CC Detect® is a serum test for colorectal cancer diagnostics. More about CC Detect® ›
- LC Detect® LC Detect® is a serum test for lung cancer diagnostics. More about LC Detect® ›
- PC Detect® PC Detect® is a serum test for prostate cancer diagnostics. More about PC Detect® ›